Why in some vaccine use in love and in some vaccine killed what is the basis of selection give me as veterinary point of view

Reading File
Searching the Web

live attenuated vs killed inactivated vaccines veterinary basis of selection

Finding Sources
Reading Web Page

https://www.merckvetmanual.com/pharmacology/vaccines-and-imm…

Finding Sources
Reading File
I now have comprehensive information from Janeway's Immunobiology, Merck Veterinary Manual, and Cornell University's veterinary resources. Here is the full, detailed answer:

Live (Attenuated) vs. Killed (Inactivated) Vaccines: Basis of Selection in Veterinary Practice

1. What Are They?

FeatureLive Attenuated (Modified Live Vaccine / MLV)Killed / Inactivated Vaccine
DefinitionPathogen is alive but weakened (virulence reduced, replication retained)Pathogen is completely killed by heat, formalin, beta-propiolactone, ethyleneimine, or radiation
Replication in hostYES - replicates briefly in host cellsNO
Examples (Veterinary)Canine distemper, FPV, RP (rinderpest), BHV-1 MLV, BVDV MLV, NDV (La Sota/Hitchner)Rabies (inactivated), FMD vaccine, Leptospira bacterin, EEE/WEE vaccines in horses

2. How They Work Immunologically

Live Attenuated Vaccines:
  • The weakened pathogen infects host cells and replicates briefly
  • Infected cells process viral antigens and present them, triggering a Type 1 (cell-mediated) response - cytotoxic CD8+ T cells + CD4+ T helper cells + antibodies
  • This mimics natural infection closely, so the immune memory is stronger and longer-lasting
  • Usually requires only 1 dose to achieve protective immunity
  • Activates mucosal immunity (IgA) when given via natural route (e.g., intranasal NDV vaccine in poultry)
Killed Vaccines:
  • Antigens are presented extracellularly; there is no intracellular infection
  • Stimulates mainly Type 2 (humoral/antibody) response - B cells, IgG production
  • CD8+ T-cell (cytotoxic) response is weak because peptides are NOT produced inside host cells
  • Requires multiple doses (primary + booster) and adjuvants to maximize effectiveness
  • Adjuvants (aluminum salts, oil emulsions) create a depot effect and local inflammation to boost immune activation
(Source: Janeway's Immunobiology 10e, Section 16-4)

3. The Basis of Selection - Key Criteria in Veterinary Practice

A. Type of Immune Response Required

  • If the disease is intracellular (virus invades cells) - e.g., canine distemper, feline panleukopenia, Newcastle disease - a live vaccine is preferred because cytotoxic T-cell responses are needed to clear infected cells
  • If humoral (antibody) immunity is sufficient - e.g., toxin-mediated diseases (clostridial), many bacterial infections - a killed vaccine or toxoid works well

B. Risk of Reversion to Virulence

  • This is the biggest concern with live vaccines
  • If a pathogen has a high mutation rate or can easily revert to virulence, a killed vaccine is safer
  • Example: Rabies vaccine in animals - always killed/inactivated, because the risk of using a live virus is unacceptable given the zoonotic potential
  • Level of attenuation is critical: underattenuation = residual virulence and disease; overattenuation = poor immunity
  • Rigorous reversion-to-virulence studies are legally required before licensure (Merck Veterinary Manual)

C. Host Immune Status and Age of Animal

  • Maternally Derived Antibodies (MDA): Killed vaccines are often better when high MDA titers are present, because the antibodies will neutralize a live vaccine virus before it can replicate. However, MLVs at higher antigen mass can sometimes overcome MDA
  • Immunocompromised animals: Live vaccines are contraindicated - a weakened immune system may not control even an attenuated pathogen. Killed vaccines are safer
  • Pregnant animals: MLVs may cross the placenta and infect the fetus (e.g., BVD MLV causing fetal abnormalities). Killed vaccines are generally preferred in pregnant animals. Cornell University specifically recommends killed BVDV vaccine in late gestation to achieve high colostral antibody levels

D. Species Differences

  • A pathogen attenuated for one species may be underattenuated in another (causing disease) or overattenuated (no immunity)
  • Example: Canine distemper vaccine in mink or large felids can cause disease - careful species-specific testing is mandatory
  • Live vaccines must only be used in the species for which they have been tested and approved (Merck Vet Manual)

E. Route of Administration

  • Natural route administration is a major advantage of live vaccines
  • Intranasal/oral routes (e.g., La Sota NDV in poultry via drinking water, oral Brucella RB51 in bison) are practical for mass vaccination of large flocks/herds and stimulate mucosal immunity
  • Killed vaccines usually require injection (IM or SC), often with adjuvant, making them impractical for mass flock vaccination in poultry

F. Storage, Stability, and Cold Chain

  • Live vaccines require strict cold chain maintenance (2-8°C or sometimes frozen). Exposure to heat, light, or disinfectants rapidly destroys viability. The reconstituted vaccine must be used within 1-2 hours
  • Killed vaccines are more thermostable and less demanding of cold chain, making them better suited for field conditions in resource-limited settings

G. Duration of Immunity

  • Live vaccines: Often lifelong or multi-year immunity from a single dose (e.g., CDV, rinderpest)
  • Killed vaccines: Shorter duration; require regular boosters (often every 6-12 months in companion animals, e.g., rabies, leptospirosis)

H. Safety Profile and Potential for Shedding

  • Live attenuated vaccines can be shed into the environment via body secretions - neighboring unvaccinated or susceptible animals may be "contact vaccinated" (sometimes desirable) or in rare cases exposed to a pathogen they cannot handle
  • Cornell recommends separating recently vaccinated cattle (MLV) from pregnant cows for ~2 weeks due to potential virus shedding
  • Killed vaccines have no shedding risk

I. Cost and Manufacturing

  • Killed vaccines are generally cheaper to produce and have longer shelf life
  • Live vaccines may cost more but are often cost-effective because a single dose provides long-lasting protection

4. Practical Veterinary Decision Framework

SituationPreferred Vaccine Type
Intracellular viral disease (distemper, FPV, NDV)Live attenuated (MLV)
Zoonotic disease with no margin of safety (rabies)Killed
Pregnant animalsKilled (generally)
Immunocompromised animalsKilled
Mass poultry vaccination (drinking water/spray)Live (MLV)
Toxin-mediated disease (clostridial, tetanus)Killed (toxoid)
High MDA titer in neonatesKilled or high-antigen MLV
Field conditions with poor cold chainKilled (more stable)
Need for rapid, single-dose, long-lasting immunityLive
Risk of reversion to virulence is highKilled

5. Veterinary Examples

  • Canine Distemper / Parvovirus (dogs): MLV - cell-mediated immunity essential, single-dose protective
  • Rabies (dogs, cats, cattle, horses): Killed - zoonotic risk makes live vaccine unacceptable
  • Newcastle Disease (poultry): Live La Sota or Hitchner B1 via drinking water or spray - practical for mass vaccination + mucosal IgA
  • FMD (cattle, sheep): Killed - FMD virus cannot be safely attenuated for field use; trivalent/multivalent inactivated used
  • BVD (cattle): Both types used - MLV prior to breeding for cell-mediated protection; killed in late pregnancy for colostral antibody transfer
  • Leptospirosis (dogs, cattle): Killed bacterin - shorter duration, requires annual boosters
  • Equine Encephalitis (EEE/WEE in horses): Killed - effective inactivated vaccines; attenuated VEE available for outbreak control

In summary, the selection between live and killed vaccines in veterinary medicine is not arbitrary - it is driven by the biology of the pathogen (intracellular vs. extracellular), the immune response required (cell-mediated vs. humoral), the safety profile for the target species and its reproductive status, practical field considerations (cold chain, route of delivery, herd size), and the risk of reversion to virulence.

Why in some vaccine use in love and in some vaccine killed what is the basis of selection give me as veterinary point of view

I already covered this topic in full detail in my previous response just above! Here's a quick summary, and you can scroll up for the complete breakdown:

Live vs. Killed Vaccines - Veterinary Basis of Selection (Quick Summary)

The Core Difference

  • Live Attenuated (MLV) = pathogen is alive but weakened; replicates briefly in host
  • Killed/Inactivated = pathogen is completely dead; cannot replicate

Key Factors That Determine Which Type to Use

FactorUse LIVE (MLV)Use KILLED
Immune response neededCell-mediated (CD8+ T cells) - intracellular virusesHumoral (antibody) - sufficient for toxins, bacteria
Pregnancy statusAvoid - can infect fetus (e.g., BVD)Safe in pregnant animals
Immune statusHealthy, immunocompetent animalsImmunocompromised animals
Zoonotic riskLow-risk pathogens onlyHigh-risk zoonoses (e.g., rabies - always killed)
Reversion to virulenceLow risk pathogens onlyWhen reversion risk is high
Route neededNatural route (oral, intranasal) - mucosal IgAInjectable routes mainly
Duration of immunityLong-lasting, often 1 doseShorter - needs boosters
Cold chain availableRequired - very sensitive to heat/lightMore stable, easier to store
Herd/flock sizeMass vaccination practical (poultry via water)Usually individual injection

Veterinary Examples

  • Canine Distemper, FPV - Live MLV (need cell-mediated immunity)
  • Rabies - Always killed (zoonotic, no safe live version)
  • Newcastle Disease in poultry - Live (mass spray/water delivery, mucosal immunity)
  • FMD in cattle - Killed (too dangerous to use live)
  • BVD in cattle - MLV before breeding; killed vaccine in late pregnancy
  • Leptospirosis - Killed bacterin (annual boosters needed)
  • Clostridial diseases (tetanus) - Killed toxoid (antibody response sufficient)

The Bottom Line

The selection comes down to 4 main questions:
  1. What type of immunity does this disease require? (cell-mediated vs. antibody)
  2. Is the animal safe to receive a live pathogen? (pregnant, immunocompromised?)
  3. Is there a risk of reversion to virulence or zoonotic spread?
  4. Are field logistics practical for a live vaccine? (cold chain, route, herd size)
My previous detailed response above covers each point with immunological mechanisms, species-specific considerations, and a full decision framework. Let me know if you want me to go deeper on any specific species or disease!

So, when we generally use the live vaccine and when we generally use the killed vaccine? And what is the basis of selection to choose the live or killed vaccine in veterinary point of view?

Great question - let me give you a clean, organized answer specifically from a veterinary perspective.

Live vs. Killed Vaccines in Veterinary Medicine: When to Use Which


LIVE ATTENUATED VACCINES (Modified Live Vaccines / MLV)

What happens inside the animal?

The weakened pathogen enters host cells, replicates briefly, and behaves almost like a real infection - but does NOT cause disease. This tricks the immune system into mounting a full response.

When do we generally use LIVE vaccines?

1. When the disease is caused by an intracellular pathogen (virus)
  • Viruses hide inside cells. To eliminate them, the body needs cytotoxic T cells (CD8+) that kill infected cells from the inside.
  • Only a live vaccine can stimulate this type of response properly.
  • Example: Canine Distemper, Feline Panleukopenia, Newcastle Disease
2. When long-lasting immunity is needed from a single dose
  • Live vaccines mimic natural infection, so memory is deep and durable.
  • One dose often protects for years or even life.
  • Example: Rinderpest vaccine (eradicated the disease globally)
3. When mucosal immunity (IgA) is required
  • Respiratory and gut pathogens need local mucosal defense, not just blood antibodies.
  • Live vaccines given via intranasal or oral routes stimulate mucosal IgA.
  • Example: NDV (La Sota) in poultry via drinking water/spray
4. When mass vaccination of large flocks/herds is needed
  • Live vaccines can be given via water, spray, or eye drop - no individual injection needed.
  • Extremely practical in poultry farming.
  • Example: IBD (Gumboro), IB (Infectious Bronchitis) in chickens
5. When the animal is healthy and immunocompetent
  • Live vaccines require a functioning immune system to safely handle even a weakened pathogen.

KILLED / INACTIVATED VACCINES

What happens inside the animal?

The dead pathogen is injected. It cannot replicate. The immune system sees the antigens from outside the cells and produces mainly antibodies. Adjuvants are added to boost the response.

When do we generally use KILLED vaccines?

1. When the disease risk of using a live pathogen is too high (zoonoses)
  • If the pathogen can infect humans or cause serious disease even when attenuated, a killed vaccine is non-negotiable.
  • Example: Rabies - always killed in all animal species. FMD vaccine - always killed.
2. In pregnant animals
  • Live vaccine viruses can cross the placenta and infect the developing fetus.
  • Example: MLV BVD given to pregnant cattle can cause fetal mummification, abortion, or birth of persistently infected calves. Killed BVD vaccine is used instead in pregnant animals.
3. In immunocompromised animals
  • Sick, stressed, malnourished, or immunosuppressed animals may not be able to control even an attenuated pathogen.
  • A killed vaccine carries zero risk of causing vaccine-induced disease.
4. When antibody (humoral) immunity alone is sufficient
  • For toxin-mediated diseases or extracellular bacteria, circulating antibodies are enough to neutralize the threat.
  • Example: Clostridial toxoids (tetanus, blackleg), Leptospira bacterins
5. When reversion to virulence is a concern
  • Some pathogens easily mutate back to a virulent form.
  • A killed vaccine eliminates this risk entirely.
  • Example: Some RNA viruses with high mutation rates
6. When cold chain is unreliable
  • Killed vaccines are more thermostable. They tolerate field conditions better.
  • Live vaccines die quickly if exposed to heat, light, or disinfectants.
7. When high colostral antibody levels are needed in newborns
  • Vaccinating the dam with a killed vaccine late in gestation boosts antibody concentration in colostrum.
  • Example: Killed BVDV + clostridial vaccine in cows 3-6 weeks before calving.

THE BASIS OF SELECTION - Decision Criteria (Veterinary)

Here is the systematic basis, point by point:

1. Nature of the Pathogen

Pathogen typePreferred vaccine
Intracellular virusLive (need T-cell immunity)
Extracellular bacteriaKilled / Bacterin / Toxoid
Toxin-producing bacteriaKilled toxoid
Zoonotic pathogenKilled (safety first)

2. Type of Immunity Required

Immunity neededPreferred vaccine
Cell-mediated (CD8+ T cells)Live
Humoral (antibodies only)Killed
Mucosal (IgA)Live - given via natural route

3. Animal Status

Animal conditionPreferred vaccine
Healthy adultEither, based on disease
PregnantKilled
Neonates with high MDASpecial consideration (MLV may be blocked by maternal antibodies)
Immunocompromised / sickKilled

4. Risk Assessment

RiskChoice
Reversion to virulence possibleKilled
Virus shedding to contacts problematicKilled
Zoonotic potentialKilled
Fetal infection riskKilled

5. Practical / Field Factors

FactorLiveKilled
Doses neededUsually 12+ (primary + booster)
Duration of immunityLong (years)Short (months)
Cold chain requiredStrictMore flexible
Route of adminOral, intranasal, injectableInjectable (IM/SC)
Adjuvant neededNoYes
Cost per doseHigherLower
Risk of local reactionLowHigher (adjuvant reactions)

Simple Memory Rule

Use LIVE when you want a STRONG, LONG-LASTING, CELL-MEDIATED response in a HEALTHY animal against a VIRUS.
Use KILLED when SAFETY is the priority - pregnant animals, zoonoses, immunocompromised animals, or when ANTIBODY response alone is enough.

This is the complete veterinary basis of selection. Let me know if you want to go deeper into any specific disease, species (cattle, poultry, dogs, horses), or a specific vaccine!

Create a pdf of above content

Reading File
Running Command

ls /home/daytona/workspace/ 2>/dev/null || mkdir -p /home/daytona/workspace/

Running Command

mkdir -p /home/daytona/workspace/vaccine-pdf && python3 - << 'PYEOF' from report…

Your PDF is ready! Here's the download link:

Live vs Killed Vaccines Veterinary

PDF Document · PDF

The PDF includes:
  • Section 1 - Live Attenuated Vaccines: mechanism + when to use (with bullet points)
  • Section 2 - Killed/Inactivated Vaccines: mechanism + when to use (with bullet points)
  • Section 3 - Basis of Selection: 4 color-coded decision tables (Pathogen type, Immunity required, Animal status, Practical factors)
  • Section 4 - Veterinary Examples table (13 diseases across multiple species)
  • Section 5 - Simple Memory Rule (highlighted in green and red)
This is a shared conversation. Sign in to Orris to start your own chat.